ADMA (NASDAQ) - ADMA Biologics Inc

Exchange: USA Stocks • Country: USA • Currency: USD • Type: Common Stock • ISIN: US0008991046
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey. Web URL:

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for ADMA (NASDAQ) - ADMA Biologics Inc
  • Uncommon Growth Rate
Market Cap. 905m USD
GiC Sector Health Care
GiC Industry Biotechnology
GiC SubIndustry Biotechnology
TER 0.00%
IPO / Inception 2013-10-17


Fundamental -2.74
Dividend -
Performance 5y -0.49
Performance TTM 2.50
Relative Performance 2.35
Analysts 4.67
Price / Fair Price TR 1.17
Price / Fair Price DCF todo


Growth TTM 84.65%
CAGR 5y -3.08%
CAGR / Mean Drawdown 5y -0.06
Sharpe Ratio TTM 1.33
Alpha vs SP500 TTM 80.05
Beta vs SP500 5y weekly 0.75
CAPM 8.70%
Average Daily Range % 4.27%
Volatility GJR Garch 1y 51.41%
Max Drawdown 5y 84%
Mean Drawdown 5y 54.4%
Price / SMA 50 9.37%
Price / SMA 200 21.41%
Current Volume 1047k
Average Volume 2350.7k


Rate TTM 0.00
Yield TTM 0.00%
Div. CAGR 5y 0.00%
Consistency of Dividends all time 0.0%